The Impact of COVID-19 is included in Pet Vaccine Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Pet Vaccine Trends and Forecast
The future of the global pet vaccine market looks promising with opportunities in the dog, cat, and rabbit applications. The global pet vaccine market is expected to reach an estimated $10.5 billion by 2030 with a CAGR of 6.1% from 2024 to 2030. The major drivers for this market are increasing adoption of pet animals, pet owners are becoming more aware of the benefits of preventive healthcare for their pets, and government regulations for vaccinations.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Pet Vaccine by Segment
The study includes a forecast for the global pet vaccine by type, vaccination, mode of administration, application, and region.
Pet Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Canlane
• Feline
Pet Vaccine Market by Vaccination [Shipment Analysis by Value from 2018 to 2030]:
• Canine Family
• Core Vaccines
• Non-Core Vaccines
Pet Vaccine Market by Mode of Administration [Shipment Analysis by Value from 2018 to 2030]:
• Injectable Vaccines
• Intranasal Vaccines
Pet Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Dogs
• Cats
• Rabbits
• Others
Pet Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Pet Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pet vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pet vaccine companies profiled in this report include-
• Elanco
• Merck
• Ceva
• Virbac
• Zoetis
• HIPRA
• Merial
Pet Vaccine Market Insights
Lucintel forecasts that canine family will remain the largest segment due to rising popularity of companion animals, the growing awareness of the importance of animal health, and the evolving lifestyles of pet owners.
Within this market, dog is expected to witness highest growth over the forecast period.
North America will remain the largest region due to strict government regulations regarding vaccination in protecting the pets from serious diseases and rising pet adoption in the USA.
Features of the Global Pet Vaccine Market
Market Size Estimates: Pet vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Pet vaccine market size by various segments, such as by type, vaccination, mode of administration, application, and region in terms of ($B).
Regional Analysis: Pet vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, vaccinations, mode of administrations, applications, and regions for the pet vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pet vaccine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the pet vaccine market size?
Answer: The global pet vaccine market is expected to reach an estimated $10.5 billion by 2030.
Q.2 What is the growth forecast for pet vaccine market?
Answer: The global pet vaccine market is expected to grow with a CAGR of 6.1% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the pet vaccine market?
Answer: The major drivers for this market are increasing adoption of pet animals, pet owners are becoming more aware of the benefits of preventive healthcare for their pets, and government regulations for vaccinations.
Q4. What are the major segments for pet vaccine market?
Answer: The future of the pet vaccine market looks promising with opportunities in the dog, cat, and rabbit applications.
Q5. Who are the key pet vaccine market companies?
Answer: Some of the key pet vaccine companies are as follows:
• Elanco
• Merck
• Ceva
• Virbac
• Zoetis
• HIPRA
• Merial
Q6. Which pet vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that canine family will remain the largest segment due to rising popularity of companion animals, the growing awareness of the importance of animal health, and the evolving lifestyles of pet owners.
Q7. In pet vaccine market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to strict government regulations regarding vaccination in protecting the pets from serious diseases and rising pet adoption in the USA.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the pet vaccine market by type (canlane and feline), vaccination (canine family, core vaccines, and non-core vaccines), mode of administration (injectable vaccines and intranasal vaccines), application (dogs, cats, rabbits, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Pet Vaccine Market, Pet Vaccine Market Size, Pet Vaccine Market Growth, Pet Vaccine Market Analysis, Pet Vaccine Market Report, Pet Vaccine Market Share, Pet Vaccine Market Trends, Pet Vaccine Market Forecast, Pet Vaccine Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Pet Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Pet Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Pet Vaccine Market by Type
3.3.1: Canlane
3.3.2: Feline
3.4: Global Pet Vaccine Market by Vaccination
3.4.1: Canine Family
3.4.2: Core Vaccines
3.4.3: Non-Core Vaccines
3.5: Global Pet Vaccine Market by Mode of Administration
3.5.1: Injectable Vaccines
3.5.2: Intranasal Vaccines
3.6: Global Pet Vaccine Market by Application
3.6.1: Dogs
3.6.2: Cats
3.6.3: Rabbits
3.6.4: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Pet Vaccine Market by Region
4.2: North American Pet Vaccine Market
4.2.1: North American Pet Vaccine Market by Vaccination: Canine Family, Core Vaccines, and Non-Core Vaccines
4.2.2: North American Pet Vaccine Market by Application: Dogs, Cats, Rabbits, and Others
4.3: European Pet Vaccine Market
4.3.1: European Pet Vaccine Market by Vaccination: Canine Family, Core Vaccines, and Non-Core Vaccines
4.3.2: European Pet Vaccine Market by Application: Dogs, Cats, Rabbits, and Others
4.4: APAC Pet Vaccine Market
4.4.1: APAC Pet Vaccine Market by Vaccination: Canine Family, Core Vaccines, and Non-Core Vaccines
4.4.2: APAC Pet Vaccine Market by Application: Dogs, Cats, Rabbits, and Others
4.5: ROW Pet Vaccine Market
4.5.1: ROW Pet Vaccine Market by Vaccination: Canine Family, Core Vaccines, and Non-Core Vaccines
4.5.2: ROW Pet Vaccine Market by Application: Dogs, Cats, Rabbits, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Pet Vaccine Market by Type
6.1.2: Growth Opportunities for the Global Pet Vaccine Market by Vaccination
6.1.3: Growth Opportunities for the Global Pet Vaccine Market by Mode of Administration
6.1.4: Growth Opportunities for the Global Pet Vaccine Market by Application
6.1.5: Growth Opportunities for the Global Pet Vaccine Market by Region
6.2: Emerging Trends in the Global Pet Vaccine Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Pet Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pet Vaccine Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Elanco
7.2: Merck
7.3: Ceva
7.4: Virbac
7.5: Zoetis
7.6: HIPRA
7.7: Merial
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Pet Vaccine Market Report.